Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Lazo-Langner

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Archives of Pathology & Laboratory Medicine|November 20, 2025
Machine Learning for JAK2 Mutation Prediction in Erythrocytosis: Context MattersBenjamin Chin-Yee, Jenny Ho, Alejandro Lazo-Langner, et al.
Pediatric Dermatology|September 24, 2017
Health-related quality of life in children with cutaneous adverse drug reactionsBlanca R Del Pozzo-Magaña, Alejandro Lazo-Langner, Michael J Rieder
Thrombosis Research|March 29, 2019
Treatment of venous thromboembolism in acute leukemia: A systematic reviewAzin Ahrari, Fatimah Al-Ani, Yimin Pearl Wang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 27, 2022
Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysisEman M Mansory, Mohammed Abu-Farhaneh, Alla Iansavitchene, et al.
Journal of Clinical Apheresis|February 22, 2013
Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantationSigny Chow, Alejandro Lazo-Langner, George Ormond, et al.
Thrombosis Research|August 18, 2020
Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolismMatthew R Kovacs, Alejandro Lazo-Langner, Martha L Louzada, et al.
Blood|December 18, 2014
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched studyMatthew Kang, Majed Alahmadi, Sonja Sawh, et al.
Thrombosis Research|November 11, 2015
Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative dataFatimah Al-Ani, Salimah Shariff, Lenicio Siqueira, et al.
European Journal of Haematology|August 28, 2023
Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysisIgor Sljivic, Adrienne Fulford, Jenny Ho, et al.
Hematology (Amsterdam, Netherlands)|December 15, 2020
Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulationKaitlin Endres, Rosanne St Bernard, Ian Chin-Yee, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Archives of Pathology & Laboratory Medicine|November 20, 2025
Machine Learning for JAK2 Mutation Prediction in Erythrocytosis: Context MattersBenjamin Chin-Yee, Jenny Ho, Alejandro Lazo-Langner, et al.
Pediatric Dermatology|September 24, 2017
Health-related quality of life in children with cutaneous adverse drug reactionsBlanca R Del Pozzo-Magaña, Alejandro Lazo-Langner, Michael J Rieder
Thrombosis Research|March 29, 2019
Treatment of venous thromboembolism in acute leukemia: A systematic reviewAzin Ahrari, Fatimah Al-Ani, Yimin Pearl Wang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 27, 2022
Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysisEman M Mansory, Mohammed Abu-Farhaneh, Alla Iansavitchene, et al.
Journal of Clinical Apheresis|February 22, 2013
Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantationSigny Chow, Alejandro Lazo-Langner, George Ormond, et al.
Thrombosis Research|August 18, 2020
Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolismMatthew R Kovacs, Alejandro Lazo-Langner, Martha L Louzada, et al.
Blood|December 18, 2014
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched studyMatthew Kang, Majed Alahmadi, Sonja Sawh, et al.
Thrombosis Research|November 11, 2015
Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative dataFatimah Al-Ani, Salimah Shariff, Lenicio Siqueira, et al.
European Journal of Haematology|August 28, 2023
Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysisIgor Sljivic, Adrienne Fulford, Jenny Ho, et al.
Hematology (Amsterdam, Netherlands)|December 15, 2020
Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulationKaitlin Endres, Rosanne St Bernard, Ian Chin-Yee, et al.
Pageof 14